Amantadine therapy for chronic hepatitis C: a dose escalation study

Author(s):
Smith JPSmith JP1, Riley TR 3rdRiley TR 3rd1, Bingaman SBingaman S1, Mauger DTMauger DT1, Shahram MirmomenShahram Mirmomen2,*
2Gastroenterologist ,Tehran University of MedicalSciences,lmam KhomeiniHospital, [email protected], Tehran, IR.Iran

Hepatitis Monthly:Vol. 4, issue 7; 83-84
Published online:Sep 30, 2004
Article type:Letter
How to Cite:JP S, 3rd R, S B, DT M, Mirmomen S. Amantadine therapy for chronic hepatitis C: a dose escalation study. Hepat Mon. 2004;4(7):. doi:

Abstract

Keywords

Full Text

Full text is available in PDF

Similar Articles

30
Sep
2004

Commentaries and points of view 2

Kamran Bagheri Lankarani,
Seyed Moayed Alavian

Bagheri Lankarani K, Alavian SM. Commentaries and points of view 2. Hepat Mon. 2004;4(8):e93016. doi:

18
Feb
2015

Telaprevir Experience From Turkey

Suheyla Komur,
Behice Kurtaran,
Ayse Seza Inal,
Husnu Pullukcu,
Aslihan Ulu,
Ferit Kuscu
,et al.

Komur S, Kurtaran B, Seza Inal A, Pullukcu H, Ulu A, et al. Telaprevir Experience From Turkey. Hepat Mon. 2015;15(2):e25639. doi: https://doi.org/10.5812/hepatmon.25639

31
Mar
2006

Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

Seyed Moayed Alavian,
Masoud Ahmadzad Asl,
maryam keshvari,
Bita Behnava,
bashir hajibeigi

Alavian SM, Ahmadzad Asl M, keshvari M, Behnava B, hajibeigi B. Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran. Hepat Mon. 2006;6(1):e92946. doi:

15
Oct
2018
A Real-Life Study of New Antiviral Therapies in a High Prevalence Geographical Area for Hepatitis C Virus Infection

A Real-Life Study of New Antiviral Therapies in a High Prevalence Geographical Area for Hepatitis C Virus Infection

Alessandro Federico,
Marcello Dallio,
Giuseppe Gerardo Caprio,
Ilario de Sio,
Gaetano Cotticelli,
Pasquale Esposito
,et al.

Federico A, Dallio M, Caprio GG, de Sio I, Cotticelli G, et al. A Real-Life Study of New Antiviral Therapies in a High Prevalence Geographical Area for Hepatitis C Virus Infection. Hepat Mon. 2018;18(10):e74224. doi: https://doi.org/10.5812/hepatmon.74224

6
Nov
2022
Hepat Mon

The Efficacy of Antiviral Treatment for Chronic Hepatitis B Patients with Normal ALT Levels: A Systematic Review and Meta-analysis

Zhe Qian,
Meixin Hu,
Houji Wu,
Hongjie Chen,
Guichan Liao,
Zixin Kang
,et al.

Qian Z, Hu M, Wu H, Chen H, Liao G, et al. The Efficacy of Antiviral Treatment for Chronic Hepatitis B Patients with Normal ALT Levels: A Systematic Review and Meta-analysis. Hepat Mon. 2022;22(1):e129836. doi: https://doi.org/10.5812/hepatmon-129836

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles